Author: OurCrowd

[Flytrex in Business Insider] Some Chick-fil-A customers can now skip the drive-thru and have their chicken sandwiches delivered by drone

Nov 20, 2023 |

Flytrex, a leader in ultrafast food delivery, today announced its longtime partner Causey Aviation Unmanned (CAU) has received an exemption from the Federal Aviation Administration (FAA) to remotely fly drones Beyond Visual Line of Sight (BVLOS) without visual observers. Extended to only a select group of companies, this approval is recognized as one of the most advanced regulatory approvals to date and sets the stage for mass scaling of CAU and Flytrex’s delivery service, after meeting certain conditions and limitations. Read more...

Read More

[OurCrowd FoodTech Fund in The Times of Israel] Now is the time to invest in Israel’s food technology startups, says global guru

Nov 20, 2023 | ,

The current global food system “simply isn’t sustainable.” That’s the stark warning from Jeremy Coller, a leading investor in alternative proteins, delivered to global investors attending ‘FoodTech on the Frontline: Invest in the Startups Feeding the Future,’ an online event hosted by OurCrowd and the Fresh Start FoodTech Incubator in Kiryat Shmona. Read...

Read More

[Beyond Meat in Food Dive] Beyond Meat makes another push into restaurants with Pizza Hut pepperoni in the UK

Nov 20, 2023 |

NEW YORK, Oct. 12, 2023 /PRNewswire/ — Madison Square Garden Sports Corp. (NYSE: MSGS) (“MSG Sports”) and Madison Square Garden Entertainment Corp. (NYSE: MSGE) (“MSG Entertainment”) announced today a new partnership with Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, naming the brand the first-ever Official Plant-Based Meat Partner of Madison Square Garden, New York Knicks, Knicks Gaming (NBA 2K League), New York Rangers, and the Arena Concert Series at Madison Square Garden. Read...

Read More

[Alpha Tau in GlobeNewswire] Alpha Tau submits to Japanese PMDA for pre-market approval of Alpha DaRT in patients with recurrent head and neck cancer

Nov 20, 2023 |

JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and HekaBio K.K. (“HekaBio”) a Japan-based healthcare investment, development and commercialization platform which is partnered with Alpha Tau, announced today that Japan’s Pharmaceuticals and Medical Devices Agency (“PMDA”) has accepted Alpha Tau’s submission requesting shonin pre-market approval of Alpha DaRT in patients with recurrent head & neck cancer, following multiple pre-submission consultation meetings with the PMDA per common practice in Japan. This submission is based upon Alpha DaRT’s clinical trial results in Japan which exceeded the target endpoints for safety and efficacy in patients with recurrent head and neck cancer. Read...

Read More